Literature DB >> 27195190

Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.

Marie-Christine Rousseau1, Karine Baumstarck2, Thierry Billette de Villemeur3, Pascal Auquier2.   

Abstract

Diverse conditions causing a very heavy and chronic motor disability, such as an advanced amyotrophic lateral, advanced form of multiple sclerosis, high spinal cord injury or a locked-in syndrom, are now getting better medical care and benefit of life support technology with consequent prolonged survival. Quality of life (QoL) assessment is being considered increasingly important to globally apprehend their general well-being. However, the motor disability that affects them appears as a substantial limitation for the assessment of their QoL and consequently a major challenge for all the community that carries an interest for them. This review discussed several avenues to provide to patients and caregivers, clinicians and researchers, and health decision making authority: i) elements to determine the most appropriate QoL measure with regard to the interest of patient's point of view, the QoL instruments suitable for this category of patients and their acceptability, ii) some arguments of the clinical relevance and accuracy of QoL assessment: interpretations of the questionnaires, QoL determinants, particularity of QoL evaluation for individuals with cognitive impairment and the caregivers perceptions of patients QoL. In conclusion, evaluation of QoL in patients with severe chronic motor handicap is a challenge of major interest, with major ethical issues. It needs to use adapted QoL scales and longitudinal following because of adaptive phenomena to the degree of handicap.

Entities:  

Keywords:  Motor handicap; caregivers; death; evaluation; quality of life

Year:  2016        PMID: 27195190      PMCID: PMC4869587          DOI: 10.5582/irdr.2016.01017

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  73 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

2.  A cross sectional study on determinants of quality of life in ALS.

Authors:  A Chiò; A Gauthier; A Montuschi; A Calvo; N Di Vito; P Ghiglione; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

3.  [Improving the quality of life and survival of cancer patients].

Authors:  J Bernheim
Journal:  Rev Med Liege       Date:  1984-02-01

4.  Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.

Authors:  R Schulz; S R Beach
Journal:  JAMA       Date:  1999-12-15       Impact factor: 56.272

5.  Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Authors:  Ruth Ann Marrie; Deborah M Miller; Gordon J Chelune; Jeffrey A Cohen
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

6.  Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics.

Authors:  N D Nelson; M Trail; J N Van; S H Appel; E C Lai
Journal:  J Palliat Med       Date:  2003-06       Impact factor: 2.947

7.  Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.

Authors:  K Baumstarck; J Pelletier; H Butzkueven; O Fernández; P Flachenecker; E Idiman; S Stecchi; M Boucekine; P Auquier
Journal:  Eur J Neurol       Date:  2013-01-24       Impact factor: 6.089

Review 8.  [Blink and you live: the locked-in syndrome].

Authors:  M-A Bruno; F Pellas; C Schnakers; P Van Eeckhout; J Bernheim; K-H Pantke; F Damas; M-E Faymonville; G Moonen; S Goldman; S Laureys
Journal:  Rev Neurol (Paris)       Date:  2008-04       Impact factor: 2.607

9.  Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.

Authors:  Emily B Bradley; Eric A Bissonette; Dan Theodorescu
Journal:  BJU Int       Date:  2004-11       Impact factor: 5.588

10.  A survey on self-assessed well-being in a cohort of chronic locked-in syndrome patients: happy majority, miserable minority.

Authors:  Marie-Aurélie Bruno; Jan L Bernheim; Didier Ledoux; Frédéric Pellas; Athena Demertzi; Steven Laureys
Journal:  BMJ Open       Date:  2011-02-23       Impact factor: 2.692

View more
  5 in total

1.  Assessment of quality of life in relation to spasticity severity and socio-demographic and clinical factors among patients with spinal cord injury.

Authors:  Meltem Vural; Ebru Yilmaz Yalcinkaya; Evrim Coskun Celik; Berrin Gunduz; Ahmet Bozan; Belgin Erhan
Journal:  J Spinal Cord Med       Date:  2018-12-03       Impact factor: 1.985

2.  Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis.

Authors:  Morten Magelssen; Trygve Holmøy; Morten Andreas Horn; Ove Arne Fondenæs; Knut Dybwik; Reidun Førde
Journal:  J Neurol       Date:  2018-09-14       Impact factor: 4.849

3.  Impact of severe polyhandicap on parents' quality of life: A large French cross-sectional study.

Authors:  Marie-Christine Rousseau; Karine Baumstarck; Sherezad Khaldi-Cherif; Catherine Brisse; Agnès Felce; Benjamin Moheng; Anderson Loundou; Thierry Billette de Villemeur; Pascal Auquier
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

4.  Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia.

Authors:  Ravi Jandhyala
Journal:  Orphanet J Rare Dis       Date:  2022-02-23       Impact factor: 4.123

5.  Time-related changes in quality of life in persons with lower limb amputation or spinal cord injury: protocol for a systematic review.

Authors:  Matthew Young; Carly McKay; Sean Williams; Peter Rouse; James L J Bilzon
Journal:  Syst Rev       Date:  2019-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.